P526: REAL-WORLD COMPARISON OF DIFFERENT TREATMENT MODALITIES FOR FAVORABLE RISK ACUTE MYELOID LEUKEMIA: STANDARD DOSE ANTHRACYCLINE VS HIGH DOSE ANTHRACYCLINE VS ADDITION OF GEMTUZUMAB OZOGAMICIN. (23rd June 2022) - Mort, J.; Brewer, B.; Mautner, B.; Dibenedetto, S.; Pierce, E.; Morse, E.; Wells, L.; Ghamsari, F.; Morris, A.; Clark, S.; Reid, J.; Patel, I.; et al.